Clinical characteristics, molecular features and in vitro susceptibility to sulbactam-durlobactam, cefiderocol, and eravacycline in NDM-1-producing versus OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates from children in Guangxi, China
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1965770 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Minxue Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Children's Hospital, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China. Hauptthemen laut MEDLINE: beta-Lactamases, Anti-Bacterial Agents, Acinetobacter baumannii, Acinetobacter Infections. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Carbapenem-resistant A. baumannii (CRAB) has been recognized as a critical priority pathogen responsible for a wide range of hospital-acquired infections.
Methods
We included pediatric CRAB infection cases at a Maternal and Child Health Hospital in Guangxi, China, from January 2019 to December 2024. The bacterial isolates had previously undergone whole-genome sequencing (WGS). An NDM-1-producing CRAB strain isolated from a bloodstream infection was subjected to Nanopore sequencing to characterize the NDM-1-encoding plasmid. We then retrospectively analyzed the risk factors for NDM-1-producing CRAB infection in children. In addition, the NDM-1-producing and OXA-23-producing CRAB strains were subjected to antimicrobial susceptibility testing (AST) against sulbactam-durlobactam, cefiderocol, and eravacycline using the micro-broth dilution method, and their susceptibility profiles were compared. Associated resistance genes were analyzed.
Results
A total of 131 pediatric patients with CRAB infections were included in this study. Based on the WGS data, 33 CRAB strains harboring bla NDM-1 were classified into the NDM-1-producing group, while 98 CRAB strains harboring bla OXA-23 were classified into the OXA-23-producing group. On multivariable analysis, indwelling urethral catheters (OR = 0.293; P = 0.009) and white blood cell (WBC) count (OR = 0.896; P = 0.039) were negatively associated with NDM-1-producing CRAB infection, yet positively associated with OXA-23-producing infections ( P < 0.05). WGS analysis revealed that 32 of the 33 (97.0%) NDM-1-producing CRAB isolates co-carried bla PER-1 , which has been reported to be associated with cefiderocol resistance in A. baumannii . Plasmid mapping showed that the same plasmid co-harbored bla NDM-1 and bla PER-1 , together with a type IV secretion system (T4SS). The resistance rate of NDM-1-producing CRAB isolates to sulbactam-durlobactam was 100%, and to cefiderocol was 66.7%—both rates being significantly higher than those observed in the OXA-23-producing group (1.0% and 0.0%, respectively; P < 0.001). However, all 131 isolates demonstrated susceptibility to eravacycline in vitro .
Conclusion
Clinical characteristics and antibiotic susceptibility differed significantly between NDM-1-producing and OXA-23-producing CRAB infections. Carbapenemase surveillance is critical for the management of CRAB infections among pediatric patients in Guangxi, China, and AST is essential to guide treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Children's Hospital, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Zitieren
APA
Liu, M., Li, M., Yan, C., Huang, L., & Zhang, H. (2026). Clinical characteristics, molecular features and in vitro susceptibility to sulbactam-durlobactam, cefiderocol, and eravacycline in NDM-1-producing versus OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates from children in Guangxi, China. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1965770
Vancouver
Liu M, Li M, Yan C, Huang L, Zhang H. Clinical characteristics, molecular features and in vitro susceptibility to sulbactam-durlobactam, cefiderocol, and eravacycline in NDM-1-producing versus OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates from children in Guangxi, China. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1965770
BibTeX
@article{Liu2026,
author = {Liu, Minxue and Li, Mengjun and Yan, Chenglan and Huang, Liying and Zhang, Huan},
title = {Clinical characteristics, molecular features and in vitro susceptibility to sulbactam-durlobactam, cefiderocol, and eravacycline in NDM-1-producing versus OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates from children in Guangxi, China},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1965770}
}
EUVIMED